Cancer Journals

blood web

cancercell web



cancerdiscovery web






cancerresearch web







clinicalcancerresearch web






molecularoncology web




naturereviewscancer web





oncogene web






oncotarget web



Blood is a weekly medical journal published by the American Society of Hematology. With an impact factor of 13.164 (2016), Blood is the most cited peer-reviewed publication in the field of hematology.








Cancer Cell provides a high-profile forum to promote major advances in cancer research and oncology. With an impact factor of 27.4 (2016), Cancer Cell is a highly cited peer-reviewed publication in the fields of cancer research and oncology.





Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials. With an impact factor of 20 (2016), Cancer Discovery publishes on topics spanning the spectrum of cancer research and medicine from the laboratory to the clinic and epidemiologic studies.


Cancer Research publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention, and epidemiologic research. With an impact factor of 9.1 (2016), Cancer Research focuses on integrated systems and technology, microenvironment and immunology, molecular and cellular pathobiology, prevention and epidemiology, therapeutics and targets, and tumor and stem cell biology.


Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. With an impact factor of 9.6 (2016), Clinical Cancer Research focuses on clinical trials evaluating new treatments and laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease.


Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational cancer research. With an impact factor of 5.3 (2016), Molecular Oncology focuses on work that significantly advances our understanding of disease processes.


Nature Reviews Cancer, with an impact factor of 37.2 (2016), will be a gateway from which cancer researchers — from those investigating the molecular basis of cancer to those involved in translational research — access the information that they need to further the ability to diagnose, treat and ultimately prevent cancer.


Oncogene publishes the latest developments in cancer research. With an impact factor of 7.5 (2016), Oncogene focuses on cellular oncogenes and their mechanism of activation; structure and function of encoded proteins; oncogenes of DNA and RNA tumor viruses; molecular oncology of human tumors; tumor suppressor genes; growth regulatory genes; cell cycle control; growth factors and receptors; apoptosis; immortalization and cellular senescence.


Oncotarget encompasses all molecules, pathways, and cellular functions common in cancer and aging, neurodegeneration and atherosclerosis, lymphocytes and neurons, cancer cells and microbes. With an impact factor of 7.5 (2016), Oncotarget focuses on eliminating the border between specialties, linking different fields of biomedical science, and fostering applications of basic and clinical science to fight disease.

Contact the Library

Phone: +1 516.367.6872
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Our librarians are here to assist you, whether you need to research a particular topic, obtain an article or book by inter-library loan, make color copies, or use any of the other services offered by the CSHL Library.